16 October 2015 - Deborah Wilkes
Archived
Johnson & Johnson has announced a US$10 billion share buyback programme but still has the funds and appetite for acquisitions.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.